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Albuminuria in nondiabetic relatives of IDDM patients with relentless decline in renal function, and increased cardio-
and without diabetic nephropathy. vascular morbidity and mortality. This late complication
Background. In non–insulin-dependent diabetes mellitus of diabetes occurs in 10 to 40% of patients with insulin-(NIDDM), there is a clustering of an elevated urinary albumin
dependent diabetes mellitus (IDDM) [1, 2].excretion rate (U-AER) in nondiabetic relatives of albuminuric
Genetic factors have been proposed to play a role inpatients. Whether this is also the case in insulin-dependent
diabetes mellitus (IDDM) is unknown. the development of diabetic nephropathy. For instance,
Methods. Overnight U-AER was measured in 186 nondia- familial predisposition to hypertension [3–5], non–insulin-
betic first-degree relatives of 80 IDDM patients with diabetic dependent diabetes mellitus (NIDDM) [6, 7], and cardio-nephropathy (U-AER . 200 mg/min or 300 mg/24 hours; DN1)
vascular disease [8] have all been implicated to increaseand in 52 relatives of 25 IDDM patients without nephropathy
the risk of diabetic nephropathy. Furthermore, albumin-(U-AER , 20 mg/min; DN2). The two groups of relatives
were comparable regarding gender distribution, age, obesity, uria has been found to cluster in siblings concordant for
blood pressure, prevalence of antihypertensive therapy, and IDDM [9–11] and NIDDM [12–14].
smoking habits. Interestingly, nondiabetic first-degree relatives of albu-Results. No difference was found in overnight U-AER be-
minuric patients with NIDDM have been found to havetween relatives of patients with DN1 and DN2 [median
an elevated urinary albumin excretion rate (U-AER)(range), 3.4 (0.1 to 372) vs. 4.0 (0.2 to 62) mg/min, respectively,
P 5 NS]. The proportion of relatives with a U-AER 5 10 mg/ compared with relatives of normoalbuminuric NIDDM
min was 12% in DN1 compared with 8% in DN2 (P 5 NS). patients [13, 15–17]. Therefore, in NIDDM, minor ab-
Among relatives of DN1, those with antihypertensive treat- normalities of U-AER seem to be present even in thement (AHT1) had higher U-AER compared with those with-
absence of diabetes in individuals with a potential geneticout [AHT1 vs. AHT2, 5.0 (0.5 to 372) vs. 3.4 (0.1 to 26.5)
susceptibility to diabetic nephropathy. The question ofmg/min, P , 0.01], a phenomenon that was not seen among
relatives of DN2[AHT 1 vs. AHT2, 3.6 (2.1 to 24.3) vs. 4.0 whether a similar elevation of U-AER is also present in
(0.2 to 61.5) mg/min, P 5 NS]. However, this analysis was nondiabetic relatives of IDDM patients with diabetic
impaired by the small number of relatives of DN2 with hyper- nephropathy has not been addressed. Therefore, the aimtension (N 5 7).
of the present study was to assess U-AER in nondiabeticConclusions. In IDDM, we found no clustering of elevated
first-degree relatives of IDDM patients with and withoutU-AER in nondiabetic relatives of patients with nephropathy.
This is different from what has been reported in NIDDM, diabetic nephropathy.
and suggests heterogeneity in the genesis of albuminuria in
diabetes.
METHODS
Subjects
Diabetic nephropathy is characterized by persistent A family study dealing with genetic factors in the gene-
albuminuria, an elevation of arterial blood pressure, a sis of diabetic nephropathy was initiated in 1994 at the
Helsinki University Central Hospital. The recruitment of
the IDDM patients with and without nephropathy hasKey words: insulin-dependent diabetes mellitus, heredity, urinary albu-
been presented in detail elsewhere [6]. In short, the familymin, arterial blood pressure, progressive renal disease, diabetic ne-
phropathies. study consists of first-degree relatives of 137 IDDM pa-
tients with diabetic nephropathy (U-AER . 200 mg/minReceived for publication July 13, 1999
or 300 mg/24 hours in two of three consecutive urineand in revised form January 26, 2000
Accepted for publication March 16, 2000 collections; DN1) attending the renal outpatient clinic
or the dialysis unit of Helsinki University Central Hospi-Ó 2000 by the International Society of Nephrology
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Table 1. Recruitment of relatives
DN1 DN2
All Parents/siblings All Parents/siblings
Total number of relatives 386 171/215 102 52/50
Alive 313 117/196 87 44/43
Contacted 247 105/142 63 36/27
Attending 231 104/127 58 35/23
Nondiabetic 209 88/121 57 34/23
U-AER available 186 77/109 52 30/22
Data are presented as number of relatives at each step.
Table 2. Characteristics of IDDM patients with (DN1) and without (DN2) diabetic nephropathy
Variable DN1 DN2 P
N 80 25 —
Male/female 52/28 8/17 ,0.01
Age years 4161 4162 NS
Duration of diabetes years 3061 2762 NS
BMI, male patients kg/m2 24.660.5 24.360.7 NS
BMI, female patients kg/m2 23.660.6 23.660.7 NS
WHR, male patients 0.9260.01 0.8560.02 ,0.05
WHR, female patients 0.8460.01 0.8060.02 ,0.01
Smoking % 33 20 NS
History of retinal photocoagulation % 91 28 ,0.001
Systolic blood pressure mm Hg 15562 12863 ,0.001
Diastolic blood pressure mm Hg 8761 7762 ,0.001
HbA1c % 8.860.2 8.160.2 ,0.05
Serum creatinine lmol/L 177 (68–1176) 78 (57–101) ,0.001
U-AERa lg/min 928 (70–8936) 4 (1–11) —
ESRD % 51 — —
Abbreviations are: BMI, body mass index; WHR, waist/hip ratio; U-AER, urinary albumin excretion rate; and ESRD, end-stage renal disease. Data are presented
as mean 6 SEM or median (range).
aNot measured in patients with ESRD
tal and of 54 patients with a normal albumin excretion had a serum creatinine slightly exceeding the reference
value of our laboratory. Exclusion of these six relativesrate (U-AER , 20 mg/min in three overnight urine col-
lections; DN2) recruited from either the diabetic outpa- had no effect on the results. Blood pressure (Korotkoff
I-V) was measured with a calibrated mercury sphygmo-tient clinic from the same hospital or the local Diabetes
Association. In total, we studied 450 first-degree relatives manometer, with the subject in sitting position after a
five-minute rest. The mean value of two recordings wasof these 191 type I diabetic patients. To assess U-AER
in the relatives, a timed overnight urine collection was used in analysis. Body weight and height were measured
in indoor clothing. Waist circumference was measuredintroduced as a part of the study protocol from Novem-
ber 1, 1995. The study protocol was approved by the midway between the iliac crest and the lowest rib, and
hip circumference was measured at the widest part oflocal ethical committee, and a written informed consent
was obtained from all participating subjects. the gluteal region, and the waist/hip ratio (WHR) was
calculated. Smoking was defined as regular smoking ofThe recruitment of the relatives is listed in Table 1.
The characteristics of the IDDM patients and their non- at least one daily cigarette, cigar, or pipe during the year
before participation in the study.diabetic first-degree relatives are presented in Tables 2 and
3, respectively. A medical history regarding medication,
Laboratory testssmoking habits, and treatment for diabetes, cardiovascular
disease, and hypertension was obtained from the rela- The urinary albumin concentration was determined by
radioimmunoassay (albumin-RIA; Pharmacia, Uppsala,tives. None of the relatives studied had a history of diabe-
tes or of any renal disorder. A timed overnight urine Sweden) with a coefficient of variation of 4%. Serum
cholesterol (normal range, 3.6 to 7.0 mmol/L), HDL-collection was performed for measurement of U-AER
and blood samples drawn for determination of HbA1c, cholesterol (normal range, women 1.10 to 2.35 and men
0.95 to 2.00 mmol/L) and triglycerides (normal range,cholesterol, high-density lipoprotein (HDL) cholesterol,
triglycerides, and creatinine. Six of the studied relatives 0.4 to 1.7 mmol/L) were all measured on a Hitachi 917
automated analyzer with enzymatic colorimetric tests.(4 fathers and 2 mothers of patients with nephropathy)
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Table 3. Characteristics of nondiabetic first-degree relatives compared with 8% in DN2 (P 5 NS). Stratified analyses
of IDDM patients with (DN1) and without (DN2)
in male [DN1 vs. DN2, 3.4 (0.1 to 372) vs. 4.2 (1.1 todiabetic nephropathy
24.3) mg/min, P 5 NS] and in female relatives [DN1 vs.
Variable DN1 DN2 P DN2, 3.5 (0.2 to 118) vs. 3.5 (0.2 to 61.5) mg/min, P 5
N 186 52 — NS] as well as in parents [DN1 vs. DN2, 3.5 (0.1 to
Male/female 85/101 22/30 NS
372) vs. 4.0 (0.2 to 61.5) mg/min, P 5 NS] and siblingsAge years 5261 5462 NS
BMI kg/m2 26.460.3 26.060.6 NS [DN1 vs. DN2, 3.4 (0.2 to 118) vs. 3.6 (0.4 to 14.4) mg/
WHR 0.8860.01 0.8660.01 ,0.05 min, P 5 NS] revealed no differences in U-AER between
Systolic blood pressure mm Hg 13862 13863 NS
the two groups of relatives.Diastolic blood pressure mm Hg 8461 8462 NS
Antihypertensive medication % 17 13 NS Of the relatives of patients with DN1, 32 (17%) rela-
Smoking % 27 25 NS tives were treated for hypertension, while the corre-
HbA1c % 5.5260.03 5.5460.06 NS
sponding number in relatives of DN2 was 7 (13%, P 5Serum cholesterol mmol/L 5.2560.08 5.6360.15 ,0.05
Serum HDL-cholesterol mmol/L 1.4760.03 1.4760.05 NS NS). Among the relatives of DN1, those with antihyper-
Serum triglycerides mmol/L 1.3160.06 1.2660.09 NS tensive treatment (AHT) had higher U-AER compared
Serum creatinine lmol/L 80 (44–128) 80 (57–112) NS
with those without [5.0 (0.5 to 372) vs. 3.4 (0.1 to 26.5)
mg/min, P , 0.01]. A similar phenomenon was not seen
among relatives of DN2, where U-AER was comparable
in relatives with and without treatment for hypertensionGlycosylated hemoglobin was measured by high-pres-
[AHT1 vs. AHT2, 3.6 (2.1 to 24.3) vs. 4.0 (0.2 to 61.5)sure liquid chromatography (normal range, 4.0 to 6.0%)
mg/min, P 5 NS].and serum creatinine by a kinetic Jaffe´ method (normal
To assess for a possible effect of impaired survivalrange, women 50 to 110 and men 55 to 115 mmol/L).
among relatives of patients with nephropathy, the rela-Urine and serum samples were stored at 2208C prior to
tives were further divided into tertiles according to agedetermination.
(Fig. 2). The tertiles corresponded to an age below 43
Statistical analysis years (tertile I), between 43 and 62 years (tertile II), and
above 62 years (tertile III). No difference in U-AERThe significance of difference in categorical variables
was observed in any of the tertiles.between the groups was tested with the chi-squared test.
To control for the varying number of relatives studiedThe significance of difference in continuous variables
per diabetic patient, we randomly selected one relative perwas tested using the Student’s t-test (normally distrib-
diabetic patient. In this analysis, no difference in U-AERuted) and with the Mann–Whitney U-test (non-normally
was observed between the two groups [DN1 (N 5 80)distributed). A two-tailed P value of less than 0.05 was
vs. DN2 (N 5 25), 3.6 (0.1 to 168) vs. 3.6 (0.2 to 61.5)considered statistically significant. Continuous variables
mg/min, P 5 NS].are presented as mean 6 SEM or median (range).
DISCUSSIONRESULTS
In this study, we found no difference in U-AER be-Table 1 depicts the recruitment of the first-degree rela-
tween nondiabetic first-degree relatives of IDDM pa-tives of the IDDM patients presented in Table 2. The
tients with and without diabetic nephropathy.proportion of parents alive was lower among parents of
Studies in both IDDM [9–11] and NIDDM [12–14] haveDN1 patients compared with parents of DN2 patients
reported a familial clustering of U-AER in siblings with(68 vs. 84%, respectively, P , 0.05). No difference was
diabetes. In addition, a recent study reported not only apresent in the proportion of living siblings between the
familial clustering of albuminuria, but also a strong concor-two groups. There were no significant differences in the
dance in the severity and pattern of glomerular lesionsproportions of living relatives that were contacted or
in IDDM sibling pairs [18]. Therefore, in the presencecontacted relatives that attended. Among the attending
of the diabetic milieu, genetic factors seem to influencerelatives, there was an excess of diabetes in relatives of
U-AER and, at least in IDDM, renal structural changes.patients with DN1 (10 vs. 2%, respectively, P 5 0.05).
Several family studies in NIDDM have consistentlyThe two groups of relatives were comparable regard-
reported elevated U-AER in nondiabetic first-degreeing gender distribution, age, body mass index, blood
relatives of NIDDM patients with microalbuminuria orpressure, and prevalence of antihypertensive therapy
macroalbuminuria when compared with relatives of nor-and smoking (Table 3). As depicted in Figure 1, over-
moalbuminuric patients [13, 15–17]. Therefore, abnormal-night U-AER did not differ between relatives of patients
ities of U-AER seem to be present even in the absencewith and without diabetic nephropathy [DN1, 3.4 (0.1
of diabetes in individuals with a potential genetic predis-to 372) vs. DN2, 4.0 (0.2 to 62), P 5 NS]. The proportion
of relatives with a U-AER · 10 mg/min was 12% in DN1 position to diabetic nephropathy. However, diabetes is
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Fig. 1. Logarithmically transformed urinary
albumin excretion rate (log U-AER) in rela-
tives of patients with (DN1) and without dia-
betic nephropathy (DN2). The horizontal
lines represent median values.
a heterogenous and complex disease entity [19], and it may sumption that the distributions of U-AER in the two
groups are unchanged, exclude a median value of 5.1be that elevation of U-AER is also caused by etiological
mechanisms of heterogeneous nature. Our finding of a mg/min or more in the relatives of patients with nephrop-
athy. The studies performed in NIDDM [13, 15, 16] havelack of similar clustering of elevated U-AER in first-
degree relatives discordant for IDDM is an interesting reported clearly elevated (approximately two times
higher) U-AER in nondiabetic relatives of patients withand new support of this view.
Since there was no difference in U-AER between rela- nephropathy compared with relatives of patients without
nephropathy. A recent study in relatives of Finnishtives of patients with and without nephropathy, the power
of the study to detect such a difference is of crucial impor- NIDDM patients found this difference to be somewhat
smaller [17]. Although our study cannot totally excludetance. According to a power calculation, our study would
have detected a difference between the groups of 0.45 in a minimal elevation of U-AER in nondiabetic relatives
of IDDM patients with nephropathy, such an elevationthe mean value of the logarithmically transformed U-AER.
In other words, since the median value for U-AER was is substantially smaller than what on average has been
reported in NIDDM. It seems justified to question the4.0 mg/min in the control group, we can, under the as-
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Fig. 2. Log U-AER in relatives of patients
with (DN1) and without diabetic nephropa-
thy (DN2) divided into age tertiles. Data are
presented as median and 25th and 75th per-
centiles. There was no difference in U-AER
between relatives of DN1 and DN2 in any
of the tertiles.
pathophysiological or biological relevance of an eleva- Elevated U-AER is associated with an increased risk
for cardiovascular morbidity and mortality [20, 21] andtion of U-AER in nondiabetic relatives of patients with
diabetic nephropathy not detected by our sample size. is more prevalent in conditions such as diabetes [22],
hypertension [23], and insulin resistance [24]. These fea-Among relatives of patients with nephropathy, rela-
tives with hypertension had higher U-AER than those tures have all been found to cluster in family members
of IDDM patients with diabetic nephropathy [3, 4, 6, 8,without. A similar effect was not seen among relatives
of patients without nephropathy. It is very tempting to 25, 26]. Therefore, since we studied U-AER in surviving
nondiabetic relatives, the influence of the selection pro-interpret this as supportive of a familial clustering to
elevated U-AER that becomes obvious only in the pres- cedure on our results must be carefully evaluated. Re-
garding survival, we found an excess of mortality amongence of an unmasking factor, in this case hypertension.
However, because of the small number of relatives with parents of patients with nephropathy. To test for an
effect of selective mortality on our results, we dividedhypertension in the control group, such conclusions can-
not be drawn on the basis of our study. It is evident, the relatives into tertiles according to their age. If there
would exist a clustering of elevated U-AER in nondia-however, that this hypothesis should be tested.
In contrast to our previous findings [4], the prevalence betic relatives of patients with nephropathy that is
masked by an impaired survival in this group, one wouldof hypertension was similar in the two groups of relatives.
In part, this could be due to the use of insensitive meth- expect this elevated U-AER to be discernible in the
younger relatives still unaffected by the effects of selec-ods, since we applied 24-hour ambulatory blood pressure
monitoring in our previous article [4]. Another explana- tive mortality. Our analysis showed no tendency toward
such a difference. Furthermore, diabetes was more com-tion may lie in the fact that the relatives were on average
14 years younger in the present study, mostly because mon among relatives of patients with nephropathy, in
line with what we have reported previously [6]. However,of the inclusion of not only parents, but also siblings.
Analyses more powerful than simple comparisons of among the siblings, in whom the prevalence of diabetes
was still very low because of their age distribution, noprevalence numbers, for instance, cumulative incidence
rates [4], were not appropriate in the present study be- difference in U-AER was observed. Taken together, al-
though we found no clear indications of a selection biascause of the small number of relatives with hypertension
in the control group. In addition, we have confirmed an to have occurred, it is still possible that an underestima-
tion of the “true” U-AER in relatives of IDDM patientsexcess of parental hypertension in patients with nephrop-
athy in the entire set of families recruited at our hospital with nephropathy may have taken place.
It is therefore of utmost importance to compare ourthus far [6], of which the present study constitutes a
subgroup. We can therefore not totally exclude a selec- results with those of the previous studies performed in
NIDDM. Gruden et al found that offspring of NIDDMtion bias of an unknown nature to have occurred despite
our attempts to minimize such a possibility. The absence patients with microalbuminuria or macroalbuminuria
had elevated U-AER compared with offspring of nor-of a clustering of hypertension in relatives of patients
with nephropathy in the present study may therefore moalbuminuric patients [15]. The study was performed
as a case-control study with 20 offspring in each group,have several explanations.
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all of whom were normotensive, had normal glucose rather than of overt nephropathy [36]. Our results may
therefore be a consequence of differences in the mecha-tolerance, and normal creatinine clearance. This obser-
vation was confirmed by Strojek et al, who found ele- nisms behind, and perhaps also in the genetic susceptibil-
ity to, elevated U-AER between IDDM and NIDDM.vated overnight and exercise-induced U-AER in 26 off-
spring of NIDDM patients with microalbuminuria and In conclusion, we found no difference in U-AER be-
tween nondiabetic first-degree relatives of IDDM patientsmacroalbuminuria compared with 30 offspring of pa-
tients with normoalbuminuria [16]. Again, the studied with and without diabetic nephropathy. This is different
from what has consistently been reported in NIDDM, andoffspring were selected to be normotensive and to have
normal oral glucose tolerance. Family studies from Italy suggests heterogeneity in the genesis of albuminuria in
diabetes.[13] and Finland [17] extended the finding to nondiabetic
siblings of NIDDM patients. In line with observations in
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